1.06.1

15:30

DEVELOPING PHARMACEUTICAL SUPPLY CHAIN RESILIENT CAPABILITIES: THE ROLE OF INDUSTRY 4.0 TECHNOLOGIES

M. Papalexi * ^[1] , A. Vafadarnikjoo ^[2] , D. Bamford ^[1] , B. Dehe ^[3]

Manchester, United Kingdom ^[1] , Sheffield, United Kingdom ^[2] , Auckland, New Zealand ^[3]

1.06.2

15:50

CONTRACTING FOR RESILIENCE IN MEDICINE SUPPLY CHAINS

K. Selviaridis * ^[1] , K. van Oorschot ^[2] , N. Dube ^[1] , M. Jahre ^[3]

Lancaster, United Kingdom ^[1] , Oslo, Norway ^[2] , Hamburg, Germany ^[3]

1.06.3

16:10

REQUIREMENTS FOR UTILIZING AND DEVELOPING PRACTICES OF STRUCTURAL FLEXIBILITY IN SUPPLY CHAINS

E. Feist * , P. Jonsson , Á. Halldórsson

Gothenburg, Sweden

1.06.4

16:30

STRATEGIES FOR ANTIFRAGILE SUPPLY CHAINS: A SYSTEMATIC REVIEW AND MULTI-CASE STUDY OF DETERMINANTS

Z. Al-Balushi * ^[1] , C. Durugbo ^[2]

Muscat, Oman ^[1] , Abu Dhabi, United Arab Emirates ^[2]